Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF).
The CCF grants and awards support cancer research done by physician-scientists at every stage of their careers.
Abramson’s Advanced Clinical Research Award (ACRA) in Breast Cancer was announced during the 50th Annual Meeting of ASCO, held recently in Chicago. Only one ACRA grant is awarded each year.
“I am thrilled and honored to receive this important grant award from the Conquer Cancer Foundation of the American Society of Clinical Oncology,” said Abramson. “This crucial funding will help support my research to improve therapies for breast cancer patients.”
Abramson will receive the ACRA in Breast Cancer grant totaling $450,000 over three years for research that includes two complementary clinical trials that use recent advances in the molecular understanding of triple negative breast cancer (TNBC).
The trials highlight novel, molecularly targeted treatments for recently defined subtypes of TNBC, which is one of the most aggressive forms of breast cancer.
This year’s ACRA award is also supported by funding from the Breast Cancer Research Foundation.
The CCF was created by cancer physicians of the American Society of Clinical Oncology (ASCO) to seek dramatic advances in the prevention, treatment and cure for all types of cancer.
Abramson received her Bachelor of Arts in English and Molecular & Cell Biology from the University of California, Berkeley, and earned her M.D. from the University of Chicago. She completed a residency in Internal Medicine at Brigham and Women’s Hospital in Boston and Hematology/Oncology training at the University of Pennsylvania, in Philadelphia. She joined the Vanderbilt faculty in 2009.
